What is the latest estimated selling price of tepotinib in 2025?

Tepotinib, as a precision targeted therapy for people with specific gene mutations in non-small cell lung cancer, has been officially launched in China and has been successfully included in the medical insurance catalog. According to current domestic market price estimates, the original version of the drug is usually 250mg/tablet, and each box usually contains 30 or 60 tablets. The price of a single box may be as high as 30,000 yuan. Although medical insurance can reimburse a certain percentage, the actual payment will fluctuate depending on regional medical insurance policies.

In order to reduce financial pressure, some patients have begun to pay attention to the overseas generic drug market, especially generic versions from Laos. At present, many Lao pharmaceutical companies, such as Lucius Pharmaceuticals, Daxiong Pharmaceuticals and ASEAN Pharmaceuticals, have launched generic tepotinib. Compared with the original drugs, these generic drugs are basically the same in terms of ingredients, dosage and usage, and are suitable for the same treatment population.

It is worth noting that due to the recent intensification of market competition and adjustment of production costs, the price of the generic version of Tepotinib launched by Laos Lucius Pharmaceuticals and Laos Daxiong Pharmaceuticals has dropped. Currently, a box (250mg*30 tablets or equivalent specifications) sells for about more than 6,000 yuan. The price advantage is significant, which greatly eases the economic burden of long-term treatment for patients.

However, although these generic drugs are legally sold locally, they may not have gone through formal approval procedures in China. When purchasing and using them, you still need to pay attention to channel legality and drug quality assurance. Especially when it comes to generic drugs, patients should avoid obtaining drugs through informal online channels to avoid encountering counterfeit drugs or preparations with unknown ingredients. It is also recommended that patients use generic drugs under the guidance of professional doctors and conduct regular follow-up monitoring to ensure that the treatment is safe and effective.

Reference materials:https://www.tepotinib.com/